Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FATE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Fate Therapeutics stock price on Thursday
(Updated on May 09, 2024)

Sell candidate since Apr 09, 2024 Loss -42.31% PDF

The Fate Therapeutics stock price gained 5.41% on the last trading day (Thursday, 9th May 2024), rising from $3.70 to $3.90. During the last trading day the stock fluctuated 9.43% from a day low at $3.71 to a day high of $4.06. The price has been going up and down for this period, and there has been a 0.78% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $14.77 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.64 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -40.30% during the next 3 months and, with a 90% probability hold a price between $2.17 and $3.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FATE Signals & Forecast

There are mixed signals in the stock today. The Fate Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.99 and $5.49. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, May 08, 2024, and so far it has risen 5.41%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Fate Therapeutics stock

Fate Therapeutics finds support from accumulated volume at $3.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.350 between high and low, or 9.43%. For the last week, the stock has had daily average volatility of 8.87%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FATE) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Fate Therapeutics to open at $3.89, and during the day (based on 14 day Average True Range), to move between $3.49 and $4.31, which gives a possible trading interval of +/-$0.410 (+/-10.52%) up or down from last closing price. If Fate Therapeutics takes out the full calculated possible swing range there will be an estimated 21.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.87 (0.77%) than the resistance at $4.04 (3.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fate Therapeutics stock A Buy?

Fate Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.466 Sell Candidate Upgraded

Predicted Opening Price for Fate Therapeutics of Friday, May 10, 2024

Fair opening price May 10, 2024 Current price
$3.89 ( 0.256%) $3.90

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.24 8.72 %
R2 4.11 5.29 %
R1 4.02 3.17 %
Current price: 3.90
Support S1 3.76 -3.68 %
S2 3.67 -5.80 %
S3 3.54 -9.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.54 16.41 %
R2 4.09 4.87 %
R1 4.04 3.59 %
Current price 3.90
Support S1 3.87 -0.769%
S2 3.80 -2.56%
S3 3.70 -5.13%

FAQ

What is the symbol for Fate Therapeutics Stock and on which exchange is it traded?
The symbol for Fate Therapeutics is FATE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fate Therapeutics Stock?
Fate Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Fate Therapeutics Stock?
Fate Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fate Therapeutics Stock.

What's the current price of Fate Therapeutics Stock?
As of the end of day on the May 09, 2024, the price of an Fate Therapeutics (FATE) share was $3.90.

What is the 52-week high and low for Fate Therapeutics Stock?
The 52-week high for Fate Therapeutics Stock is $8.83 and the 52-week low is $1.63.

What is the market capitalization of Fate Therapeutics Stock?
As of the May 09, 2024, the market capitalization of Fate Therapeutics is 421.123M.

When is the next earnings date for Fate Therapeutics?
The upcoming earnings date for Fate Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT